Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Generative AI promises to be the next great leap forward in artificial intelligence. But to deliver on this promise, brands must adopt an approach that puts humans at the center. In this report, Criticaleye’s CEO ...
Artificial Intelligence, a force with the potential to revolutionise various aspects of people's lives and business operations, demands responsible and ethical decision-making. This is particularly crucial in HR. Cr...
This research, conducted at our HR Director Retreat, highlights the executive focus on business performance and ensuring the right leadership capabilities are in place to drive change and success. Key findings from C...
Displaying 1 to 3 of 1,669
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
